Drawing for GENOPREP

USPTO serial 75788109

GENOPREP

Reviewed by CopyMark Law Group

Reg. 2777094Status 710
Filing date
Status date
Registration date
Oct 28, 2003
Examiner
KLINE, MATTHEW
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with GENOPREP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MARTIN R GREENSTEIN

Martin R. Greenstein TechMark a Law Corporation4820 Harwood Road, 2nd FloorSan Jose, CA 95124-5273UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical reagents for manual and automated use in DNA sequencing, cytokine genotyping, DNA isolation from blood samples, mitochondria specific gene amplifications, DNA isolation from buccal cells and DNA isolation from tissue sections; chemical reagents for manual and automated use in RNA isolation from serum and blood plasma; cultured cells, human tissue, animal tissue, plant tissue and yeast cells; chemical reagents for manual and automated use in biological analysis systems and biochips; chemical reagents for manual and automated use in determining and surveying of gene sequences; chemical reagents used for manual and automatic isolation, preparation and analysis of gene material from biological samples; cell cultures for use in scientific or medical research; chemical reagents and preservatives for storage of isolated DNA, RNA, cell and tissue samples, blood samples, organs and organisms; chemical tissue homogenizers; chemical reagents for isolation and preparation of gene materials from biological samples; streptavidin beads and mRNA beads for use in DNA and RNA isolation and analysis; red cell lysis solutions; binding solutions; lyophilized powder; sequence specific primers for use in DNA and RNA isolation and analysisSECTION 8 - CANCELLED—
005Pharmaceuticals and pharmaceuticals reagents for manual and automated use in DNA sequencing, cytokine genotyping, DNA isolation from blood samples, mitochondria specific gene amplifications, DNA isolation from buccal cells and DNA isolation form tissue sections; pharmaceuticals and pharmaceutical reagents for manual and automated use in RNA isolation from serum and blood plasma, cultured cells, human tissue, animal tissue, plant tissue and yeast cells; pharmaceuticals and pharmaceutical reagents for Manual and automated use in biological analysis systems and biochips; pharmaceuticals and pharmaceutical reagents for manual and automated use in determining and surveying gene sequences; pharmaceuticals and pharmaceutical reagents used for manual and automatic isolation, preparation, and analysis of gene material from biological samples; cell cultures for use in scientific or medical research; pharmaceuticals, pharmaceutical reagents and preservatives for storage of isolated DNA, RNA, cell and tissue samples, blood samples, organs and organisms; pharmaceutical tissue homogenizes; pharmaceuticals and pharmaceutical reagents for isolation and preparation of gene materials from biological samples; streptavidin beads and mRNA beads for use in DNA and RNA isolation and analysis; red cell lysis solutions; binding solutions; lyophilised powder; sequence specific primers for use in DNA and RNA isolation and analysisSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 5, 2010C8..CANCELLED SEC. 8 (6-YR)—
Aug 5, 2008CFITCASE FILE IN TICRS—
Jan 14, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 28, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 5, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 16, 2003NPUBNOTICE OF PUBLICATION—
Jun 5, 20031.BDSec. 1(B) CLAIM DELETED—
Jun 4, 2003IUCNNOTICE OF ALLOWANCE CANCELLED—
Dec 10, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 17, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 28, 2002NPUBNOTICE OF PUBLICATION—
Jun 26, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 19, 200244DDSEC. 44(D) CLAIM DELETED—
Jun 19, 2002CNEAEXAMINERS AMENDMENT MAILED—
Jun 7, 2002JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Jun 7, 2002EXPIEX PARTE APPEAL-INSTITUTED—
May 1, 2002EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Nov 1, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 30, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 27, 2001CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 16, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 24, 2000CNSLLETTER OF SUSPENSION MAILED—
Aug 14, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 16, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 3, 2000DOCKASSIGNED TO EXAMINER—
Dec 14, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance